TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
135 hedge funds and large institutions have $438M invested in Tvardi Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 35 increasing their positions, 43 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
+1
Holders Change %
+0.75%
% of All Funds
2.93%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
22
Increased
35
Reduced
43
Closed
21
Calls
$16.3M
Puts
$15.6M
Net Calls
+$717K
Net Calls Change
+$2.06M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$5.25M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$3.92M |
| 3 |
First Manhattan
New York
|
+$2.84M |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
+$2.39M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.38M |
Top Sellers
| 1 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$7.62M |
| 2 |
State Street
Boston,
Massachusetts
|
-$7.01M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.69M |
| 4 |
Millennium Management
New York
|
-$5.67M |
| 5 |
Renaissance Technologies
New York
|
-$5.37M |
